Royalty Pharma plc (RPRX) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$67.27

$1.34 (2.02%)

Last update: 03:52 PM EST

Day's range

$66.4

$67.71

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
04/21/2026	UBS	Ashwani Verma	$57.00	$49.30	15.62%
04/10/2026	Morgan Stanley	Terence Flynn	$63.00	$47.98	31.31%
02/12/2026	Morgan Stanley	Terence Flynn	$61.00	$44.71	36.43%
01/30/2026	UBS	Ashwani Verma	$49.00	$40.86	19.92%
07/10/2025	Morgan Stanley	Terence Flynn	$54.00	$36.14	49.41%
09/04/2024	Goldman Sachs	Chris Shibutani	$51.00	$29.16	74.93%
07/11/2024	Morgan Stanley	Terence Flynn	$51.00	$25.73	98.21%
06/07/2024	Goldman Sachs	Chris Shibutani	$50.00	$27.09	84.57%
06/03/2024	UBS	Ashwani Verma	$28.00	$27.35	2.38%
06/13/2022	UBS	Ashwani Verma	$47.00	$38.46	22.2%

Royalty Pharma plc FAQ's

Royalty Pharma plc has been rated by research analysts at Morgan Stanley, Goldman Sachs, UBS, Seaport Global, Leerink Partners in the past 90 days.